A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease
Cohen, M.; Demers, C.; Bigonzi, F.; Gurfinkel, E.P.; Turpie, A.G.G.; Fromell, G.J.; Goodman, S.; Langer, A.; Califf, R.M.; Fox, K.A.A.; Premmereur, J.; E, E.N. M.
The new England Journal of Medicine 337(7): 447-452
1997
ISSN/ISBN: 0028-4793 Accession: 073633441
PDF emailed within 1 workday: $29.90
Related References
Klein, W.; Buchwald, A.; Hillis, S.E.; Monrad, S.; Sanz, G.; Turpie, A.G.G.; Van der Meer, J.; Olaisson, E.; Undeland, S.; Ludwig, K.; Fric, I. 1997: Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease fragmin in unstable coronary artery disease study (FRIC) Circulation 96(1): 61-68Klein, W.; Buchwald, A.; Hillis, S.E.; Monrad, S.; Sanz, G.; Turpie, A.G.; van der Meer, J.; Olaisson, E.; Undeland, S.; Ludwig, K. 1997: Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC) Circulation 96(1): 61-68
Cohen, M.; Demers, C.; Gurfinkel, E.P.; Turpie, A.G.; Fromell, G.J.; Goodman, S.; Langer, A.; Califf, R.M.; Fox, K.A.; Premmereur, J.; Bigonzi, F. 1997: A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group New England Journal of Medicine 337(7): 447-452
Ziegelhoeffer A.; De Jong J.W.; Ferrari R.; Turi Nagy L. 2001: Randomized trial of low molecular weight heparin (enoxaparin) vs. unfractionated heparin for unstable coronary artery disease: 1-year results of the ESSENCE study Acc Current Journal Review 10(1): 15-0
Goodman, S.G.; Cohen, M.; Fox, K.A.A.; Langer, A.; Bigonzi, F.; Gurfinkel, E.P.; Radley, D.R.; Le Iouer, V.; Fromell, G.J.; Demers, C.; Turpie, A.G.G.; Califf, R.M. 2000: Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable Coronary artery disease : One-year results of the ESSENCE study J. Am. Coll. Cardiol 36(3): 693-698
Goodall, A.H.; Knight, C. 1998: Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease New England Journal of Medicine 338(2): 130-131
Baker, B.A.; Adelman, M.D. 1998: Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease New England Journal of Medicine 338(2): 130; Author Reply 131
Kearon, C. 1998: Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease New England Journal of Medicine 338(2): 129-130; Author Reply 131
Krulewitz, A. 1998: Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease New England Journal of Medicine 338(2): 130; Author Reply 131
Goodman, S.G.; Cohen, M.; Bigonzi, F.; Gurfinkel, E.P.; Radley, D.R.; Le Iouer, V.; Fromell, G.J.; Demers, C.; Turpie, A.G.; Califf, R.M.; Fox, K.A.; Langer, A. 2000: Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events Journal of the American College of Cardiology 36(3): 693-698
Kauw, F.H.; Cleophas, T.J.; Kalmansohn, R.B. 1998: Low molecular weight heparins better than unfractionated heparin in unstable coronary artery disease? Unstable angina pectoris/non-Q wave infarction a partly outpatient clinic condition? International Journal of Clinical Pharmacology and Therapeutics 36(7): 392-397
Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264
Mattioli, A.V.; Sormani, L.; Goedecke, L.; Molinari, R.; Castellani, E.T.; Mattioli, G. 1998: Comparison between a very low molecular weight heparin and unfractionated heparin in patients with unstable angina A pilot study Journal of the American College of Cardiology 31(2 Suppl A): 488A
Bijsterveld, N.R.; Moons, A.H.; Meijers, J.C.M.; Tijssen, J.G.P.; Büller, H.R.; Levi, M.; Peters, R.J.G. 2002: Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin Journal of the American College of Cardiology 39(5): 811-817
Monroe, M.L.; Kon, N.D.; Byerly, W.G.; Reichert, M.G. 2001: The effects of pre-operative low molecular weight heparin versus unfractionated heparin on bleeding in coronary artery bypass graft patients Pharmacotherapy 21(10): 1264
Kodumuri, V.; Adigopula, S.; Singh, P.; Swaminathan, P.; Arora, R.; Khosla, S. 2011: Comparison of low molecular weight heparin with unfractionated heparin during percutaneous coronary interventions: a meta-analysis American Journal of Therapeutics 18(3): 180-189
Bonan, R.; Peisack, M.B.; Karsch, K.R.; Group, T.R.duce Study 1996: Comparison between unfractionated heparin and low molecular weight heparin during percutaneous transluminal coronary angioplasty in the 24 hours after intervention Journal of the American College of Cardiology 27(2 Suppl A): 84A
Jun, L.; Arnout, J.; Vanhove, P.; Dol, F.; Lormeau, J.C.; Herbert, J.M.; Collen, D.; Van de Werf, F. 1995: Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs Coronary Artery Disease 6(3): 257-263
Jun, L.; Arnout, J.; Vanhove, P.; Dol, F.; Lormeau, J.C.; Herbert, J.M.; Collen, D.; Van de Werf, F. 1995: Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs Coronary Artery Disease 6(3): 257-263
Wallentin, L.; Bergstrand, L.; Dellborg, M.; Fellenius, C.; Granger, C.B.; Lindahl, B.; Lins, L.E.; Nilsson, T.; Pehrsson, K.; Siegbahn, A.; Swahn, E. 2003: Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study European Heart Journal 24(10): 897-908